Instil Bio (TIL) Operating Leases (2022 - 2026)

Instil Bio has reported Operating Leases for 5 years, with the latest figure at $2.2 million in Q2 2026.

• On a quarterly basis, Operating Leases rose 382.25% year-over-year to $2.2 million in Q2 2026; TTM through Jun 2026 was $2.2 million, a 382.25% increase from a year earlier, with the FY2024 full-year figure at $1.0 million, down 64.65% from the prior year.
• Operating Leases was $2.2 million for Q2 2026 at Instil Bio, up from $305000.0 in the prior quarter.
• The five-year high for Operating Leases was $8.4 million in Q1 2022, with the low at $305000.0 in Q3 2025.
• Average Operating Leases over 5 years is $4.2 million, with a median of $3.9 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Operating Leases plunged 90.38% in 2025, then soared 382.25% in 2026.
• Over 5 years, Operating Leases stood at $5.2 million in 2022, then sank by 44.36% to $2.9 million in 2023, then sank by 64.65% to $1.0 million in 2024, then tumbled by 70.01% to $305000.0 in 2025, then jumped by 630.49% to $2.2 million in 2026.
• The last three Operating Leases figures came in at $2.2 million (Q2 2026), $305000.0 (Q3 2025), and $462000.0 (Q2 2025), per Business Quant data.